A retrospective study of docetaxel and bevacizumab as a second- or later-line chemotherapy for non-small cell lung cancer

Comparative results of second- or later-line bevacizumab plus docetaxel and docetaxel alone for patients with NSCLC have never been reported. In order to evaluate the combined effect of bevacizumab and docetaxel as second- or later-line chemotherapy for NSCLC, a retrospective study was performed. Be...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Mol Clin Oncol
Hauptverfasser: Kurishima, Koichi, Watanabe, Hiroko, Ishikawa, Hiroichi, Satoh, Hiroaki, Hizawa, Nobuyuki
Format: Artigo
Sprache:Inglês
Veröffentlicht: D.A. Spandidos 2017
Schlagworte:
Articles
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5492640/
https://ncbi.nlm.nih.gov/pubmed/28685090
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2017.1282
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge